We have observed
9 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
December 16, 2012).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NANOIRON-BASED OXYGEN SCAVENGERS
A PLANT HOMOLOG TO AUTOPHAGY PROTEIN P62
ASYMMETRICALLY SUBSTITUTED ANTHRAPYRIDAZONE DERIVATIVES AS CYTOSTATICS
MEDICAL MATERIAL, THE METHOD OF ITS PRODUCTION AND USE OF THE MEDICAL MATERIAL
MEDICAL MATERIAL FOR RECONSTRUCTION OF BLOOD VESSELS, THE METHOD OF ITS PRODUCTION AND USE OF THE MEDICAL MATERIAL FOR RECONSTRUCTION OF BLOOD VESSELS
USE OF A MIR172 MOLECULE FOR DECREASING INFLAMMATION
NUCLEOTIDE ANALOGUE, METHOD OF SYNTHESIS OF NUCLEOTIDE ANALOGUE, USE OF NUCLEOTIDE ANALOGUE, ANTIVIRAL PRO-NUCLEOTIDE, PHARMACEUTICAL COMPOSITION
ANTIGEN, INFLUENZA VACCINE, SYSTEM FOR VACCINE MANUFACTURING, METHOD OF ANTIGEN PRODUCTION, AND USE OF ANTIGEN TO PRODUCE AN INFLUENZA VACCINE
USE OF CATIONIC DERIVATIVES OF POLYPRENOLS PTAI IN PRODUCTION OF IMMUNOMODULATING SUBSTANCES